Zealand Pharma A/S (ZEAL) — Cash Flow Reinvestment Rate
Zealand Pharma A/S (ZEAL) has a Cash Flow Reinvestment Rate of 0.19x as of June 2025, reinvesting Dkr1.58 Billion (capex Dkr6.73 Million plus investments Dkr-1.57 Billion) from operating cash flow of Dkr8.52 Billion. See Zealand Pharma A/S (ZEAL) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zealand Pharma A/S Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for Zealand Pharma A/S across 3 annual periods. For the full cash flow conversion analysis, see Zealand Pharma A/S cash flow conversion.
Annual Cash Flow Reinvestment Rate for Zealand Pharma A/S (2012–2025)
Year-by-year capital reinvestment analysis for Zealand Pharma A/S. See how financially flexible is Zealand Pharma A/S to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (DKK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | Dkr33.37 Million | Dkr6.53 Billion | Dkr33.37 Million | ▼ -99.9% |
| 2016 | 7.40x | Dkr302.56 Million | Dkr40.90 Million | Dkr2.60 Million | ▲ +5628.9% |
| 2012 | 0.13x | Dkr8.85 Million | Dkr68.54 Million | Dkr8.85 Million | — |